Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. General prognosis is favourable in untreated women.

Benzer Materyaller

• Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. No cytogenetic data were reported.
  Yazar:: Kingdom, J., ve diğerleri
  Baskı/Yayın Bilgisi: (1997)
• Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
  Yazar:: Rai, R., ve diğerleri
  Baskı/Yayın Bilgisi: (1997)
• Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. During pregnancy, heparin should be stopped during labour and then restarted soon after delivery.
  Yazar:: Piette, J. C., ve diğerleri
  Baskı/Yayın Bilgisi: (1997)
• Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant
  Yazar:: Empson, Marianne B, ve diğerleri
  Baskı/Yayın Bilgisi: (2005)
• Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage
  Yazar:: Elmahashi, Mohamed O, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)